As of March 2025 Marksans Pharma has a market cap of S$1.52 Billion. This makes Marksans Pharma the world's 5316th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | S$1.52 B | -28.08% |
2024 | S$2.11 B | 85.4% |
2023 | S$1.14 B | 201.33% |
2022 | S$0.37 B | -15.2% |
2021 | S$0.44 B | -0.42% |
2020 | S$0.44 B | 247.49% |
2019 | S$0.12 B | -41.98% |
2018 | S$0.22 B | -34.76% |
2017 | S$0.34 B | -1.76% |
2016 | S$0.34 B | -61.9% |
2015 | S$0.91 B | 84.79% |
2014 | S$0.49 B | 254.95% |
2013 | S$0.13 B | 397.92% |
2012 | S$27.93 M | 82.81% |
2011 | S$15.27 M | -60.94% |
2010 | S$39.12 M | -38.33% |
2009 | S$63.43 M | -18.74% |
2008 | S$78.06 M | -80.94% |
2007 | S$0.40 B | 203.43% |
2006 | S$0.13 B |